Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Eptifibatide Solution for Injection 75 mg
  Indications :
 

Acute Coronary Syndrome

Patients undergoing PCI (Percutaneous Coronary Intervention)

   
  Dosage :
  Bolus dose followed by I.V Administration.

unigrilin_table


Renally Impaired Patients :

Acute coronary syndrome : CrCl <50 mL/minute: Use 180mcg/kg bolus (max. : 22.6mg)
& 1 mcg/kg/minute infusion (maximum: 7.5 mg/hour).

Percutaneous coronary intervention (PCI) with or without stenting :
CrCl <50 mL/minute : Use 180 mcg/kg bolus (maximum: 22.6 mg) administered immediately before the initiation of PCI and followed by a continuous infusion of 1 mcg/kg/minute (maximum : 7.5 mg/hour). A second 180 mcg/kg (maximum : 22.6 mg) bolus should be administered 10 minutes after the first bolus.
   
  Packing : 4 Vials of 75 mg/100 ml
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.